A Study of Continued Treatment With Regorafenib in Participants With Solid Tumors Who Have Participated in Other Bayer Studies
Clinical trial NCT06246643 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06246643
- Sponsor
- Bayer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-24
- Primary completion
- 2028-04-27
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.